SummitReheis UK Gains FDA Certification
SummitReheis is pleased to announce that Alembic Manufacturing Limited, its joint venture partner in the United Kingdom, has been successfully registered as a Drug Establishment with the United States Food and Drug Administration, and the initial registration is current through December 31, 2017. Alembic produces USP quality antiperspirant actives which are supplied by SummitReheis to its customers in the UK and other European markets.
Alembic is a quality leader which is also ISO 9001 certified and accredited by the EFfci (European Federation for Cosmetic Ingredients) for the GMP production of cosmetic ingredients. It has been producing antiperspirant actives in the UK since 1990 and the Joint Venture Agreement with SR was originally established in 2003. Like SR’s other facilities in the United States, Germany, and China, Alembic is also an environmental leader and is registered with the UK Environment Agency as a low impact site equivalent to a zero discharge plant in United States regulatory terms.
Please direct inquiries to Joe Andriac (email@example.com) or Philip Klepak (firstname.lastname@example.org).